Active ingredientCamostatCat. No. P-C014-001CAS 59721-28-7Family · Pharmaceutical analytical standards
Camostat
An inhibitor of serine proteases, enzymes that cut proteins, first marketed in Japan in 1985 as tablets for chronic pancreatitis and for reflux oesophagitis after surgery. This family brings together the active ingredient.
Did you know?In 2020 a laboratory study showed that SARS-CoV-2 uses the enzyme TMPRSS2 to enter cells and that camostat blocks this entry: as a result it was tested against COVID-19.
Go to the active ingredient →Active ingredientCamostatCat. No. P-C014-001CAS 59721-28-7
Active ingredientCamostat HClCat. No. P-C014-002CAS 410077-21-3
Active ingredientCamostat MesylateCat. No. P-C014-003CAS 59721-29-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.